Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 19Esophageal Squamous Cell Carcinoma 5Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Ovarian Neoplasms 2Neoplasm, Residual 2Neoplasm Metastasis 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Turcot syndrome 1Testicular Neoplasms 1Surgery 1Stress, Psychological 1Squamous Cell Carcinoma of External Auditory Canal 1Solitary Fibrous Tumor, Pleural 1Seminoma 1Recurrence 1Postoperative Complications 1

Interventions

Bevacizumab 69atezolizumab 54lenvatinib 42durvalumab 42Nivolumab 38pembrolizumab 35tremelimumab 28Magnetic Resonance Spectroscopy 21Specimen Handling 19tislelizumab 18sintilimab 17Ipilimumab 15Sorafenib 14regorafenib 13cabozantinib 13Radiosurgery 13Radiotherapy 12apatinib 11Blood Specimen Collection 11Immunoglobulin G 10camrelizumab 9Immune Checkpoint Inhibitors 9Disulfides 9X-Rays 8Cyclophosphamide 8donafenib 7Oxaliplatin 7Immunotherapy 7Folfox protocol 7Fluorouracil 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Neoadjuvant Therapy × 1 year × Clear all
NCT06045975 2026-04-24

DUMELEP

Assistance Publique - Hôpitaux de Paris

Phase 2 Active not recruiting
30 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06405321 2026-01-14

Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma

Guangxi Medical University

Recruiting
2,000 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04727307 2025-09-30

AB-LATE02

University Hospital, Montpellier

Phase 2 Recruiting
202 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡